SAN DIEGO, March 20, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody ...

Opus Genetics (IRD) announced that three abstracts on its investigational gene therapy candidates have been accepted for presentation at the Association for Research in Vision and Ophthalmology ...

Each term BILL will offer Special Presentations — periodic lectures by distinguished presenters on new, interesting topics. These special, one-time presentations on a variety of educational issues are ...